FibroBiologics, Inc.
FBLG•NASDAQ•Healthcare•Biotechnology

About FibroBiologics

FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases, including wound healing, multiple sclerosis, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications. The company was founded in 2021 and is based in Houston, Texas.

Company Information

SectorHealthcare
IndustryBiotechnology
CEOPeter O’Heeron
Founded2021
IPO DateJanuary 31, 2024
Employees13
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Websitefibrobiologics.com
Phone281 651 5150
Address
455 East Medical Center Boulevard, Suite 300 Houston, Texas 77598 United States

Corporate Identifiers

CIK0001958777
CUSIP31573L105
ISINUS31573L1052
EIN86-3329066
SIC2834

Leadership Team & Key Executives

Peter O'Heeron
Founder, Chairperson and Chief Executive Officer
Dr. Hamid Khoja Ph.D.
Chief Scientific Officer
Ruben A. Garcia J.D.
General Counsel